Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>A=Sehested, Maxwell$<.>)
Общее количество найденных документов : 27
Показаны документы с 1 по 20
 1-20    21-27 
1.
Treatment of experimental extravasation of amrubicin, liposomal doxorubicin, and mitoxantrone with dexrazoxane // Cancer Chemother. and Pharmacol., 2012. Vol. 69, N 2.-С.573-576

2.
Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy // Toxicology, 2009. Vol. 255, N 1-2.-С.72-79

3.
A dual mechanism of action of the anticancer agent F11782 on human topoisomerase II 'альфа' // Biochem. Pharmacol., 2003. Vol. 66, N 4.-С.623-631

4.
A dual mechanism of action of the anticancer agent F11782 on human topoisomerase II 'альфа' // Biochem. Pharmacol., 2003. Vol. 66, N 4.-С.623-631

5.
Langer Seppo W. Treatment of anthracycline extravasation with dexrazoxane // Clin. Cancer Res., 2000. Vol. 6, N 9.-С.3680-3686

6.
Langer Seppo W. Treatment of anthracycline extravasation with dexrazoxane // Clin. Cancer Res., 2000. Vol. 6, N 9.-С.3680-3686

7.
Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity // Clin. Cancer Res., 1999. Vol. 5, N 10.-С.2899-2907

8.
Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity // Clin. Cancer Res., 1999. Vol. 5, N 10.-С.2899-2907

9.
Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity // Clin. Cancer Res., 1999. Vol. 5, N 10.-С.2899-2907

10.
Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity // Clin. Cancer Res., 1999. Vol. 5, N 10.-С.2899-2907

11.
Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: A tyr49Phe mutation confers high-level resistance to bisdioxopiperazines // Cancer Res., 1998. Vol. 58, N 7.-С.1460-1468

12.
Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: A tyr49Phe mutation confers high-level resistance to bisdioxopiperazines // Cancer Res., 1998. Vol. 58, N 7.-С.1460-1468

13.
Essential mitotic fuctions of DNA topoisomerase II'альфа' are not adopted by topoisomerase II'бета' in human H69 cells // J. Biol. Chem., 1998. Vol. 273, N 50.-С.33660-33666

14.
E2F-1-Induced p53-independent apoptosis in transgenic mice // Oncogene, 1998. Vol. 17, N 2.-С.143-155

15.
Sorensen pH-dependent regulation of campothecin-induced cytotoxicity and cleavable complex formation by the antimalarial agent chloroquine // Biochem. Pharmacol., 1997. Vol. 54, N 3.-С.373-380

16.
Sorensen pH-dependent regulation of campothecin-induced cytotoxicity and cleavable complex formation by the antimalarial agent chloroquine // Biochem. Pharmacol., 1997. Vol. 54, N 3.-С.373-380

17.
Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation // Blood, 1995. Vol. 85, N 3.-С.812-817

18.
Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments // Cancer Res., 1994. Vol. 54, N 11.-С.2959-2963

19.
Relationship of VP-16 to the classical multidrug resistance phenotype // Cancer Res., 1992. Vol. 52, N 10.-С.2874- 2879

20.
Demant Erland J.F. Characterization of the cooperative cross-linking of doxorubicin N-hydroxysuccinimide ester derivatives to water soluble proteins // Biochim. et biophys. acta. Protein Struct. and Mol. Enzymol., 1991. Vol. 1118, N 1.-С.83-90

 1-20    21-27 
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)